Attention-deficit drugs like Adderall and Ritalin have helped millions of ADHD kids get along. For a new generation, they’ve also fed a black market in college dorms and high-pressure labs, where off-label use by the non-ADHD gets term papers written and lab reports done.
Now, pharmaceutical companies — and some scientists — are saying maybe we should consider “cognitive enhancers,” drugs like these, for the general population.
Some call it “cosmetic neurology,” and say it’s time. Others say it’s a bad, bad idea.
This hour, On Point: The debate over drugs for the mind.